Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIp Group Regulatory News (IPO)

Share Price Information for Ip Group (IPO)

Share Price is delayed by 15 minutes
Get Live Data
66.20    -1.80 (-2.65%)
Bid:
65.90
Ask:
66.70
Spread: 0.80 (1.214%)
Market Cap: £584.83m
IPO Live PriceLast checked at - London Stock Exchange

Intraday Ip Group Share Chart

Board changes

4 May 2018 07:00

RNS Number : 1008N
IP Group PLC
04 May 2018
 

FOR RELEASE ON

04 May 2018

 

IP Group plc - Board changes

 

IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the Company"), the developer of intellectual property-based businesses, announces that Mike Humphrey has indicated that for personal reasons he wishes to retire and step down from his position as Non-executive Chairman and a director of the Company as soon as a suitable replacement can be recruited.

 

Mr Humphrey joined the Board of IP Group in October 2011 as a non-executive Director and became Non-executive Chairman in March 2015. He has served as Senior Independent Director, Chairman of the Remuneration Committee and is currently Chairman of the Nomination Committee and a member of the Remuneration Committee.

 

In addition, IP Group announces that Heejae Chae has been appointed as Non-executive Director with immediate effect while Professor Lynn Gladden has indicated that she will be stepping down from her role as Non-executive Director on or prior to 31 December 2018. Professor Gladden has been appointed to the role of Executive Chairman of the Engineering and Physical Sciences Research Council (EPSRC) with effect from 1st of October and, as such, will need to step down from her role at IP Group to avoid any potential conflict of interests.

 

Mr Chae is currently Chief Executive of AIM-listed Scapa Group plc, a global supplier of products for healthcare and industrial markets. Prior to joining Scapa, Mr Chae was Group Chief Executive of Volex Group plc. He was previously the Group General Manager, Radio Frequency Worldwide, for Amphenol Corporation. He spent the early part of his career in finance at The Blackstone Group and Credit Suisse First Boston before moving into industry. Mr Chae has degrees in Economics and Engineering from Columbia University and an MBA from Harvard University. Mr Chae also serves on the Board of Overseers at Boston Children's Hospital and is an Advisory Council Member at Columbia University.

 

Alan Aubrey, Chief Executive of IP Group, said: "Mike has made a significant contribution to the growth of IP Group during his tenure. On behalf of the Board and all of the Company's staff, I would like to thank Mike for his hard work and wise counsel over the years and to wish him well. I would also like to express my thanks to Lynn for her contribution over the last four years and I'm delighted to welcome Heejae Chae to the Board and look forward to working with him."

 

Mike Humphrey, Chairman, said: "Since joining IP Group, the Company has undergone a rapid period of growth which has seen a near ten-fold increase in the value of the portfolio as well as expansion into both the US and Australasia. It has been an honour to work alongside such a talented team and I am confident that the Group will go from strength to strength."

 

A further announcement will be made in due course once Mr Humphrey's replacement has been selected.

 

This announcement is made pursuant to Listing Rule 9.6.11R. There are no other details required to be disclosed under Listing Rule 9.6.13R. There are no further disclosures required under the Disclosure and Transparency Rules.

 

For more information, please contact:

 

IP Group plc

www.ipgroupplc.com

Alan Aubrey, Chief Executive OfficerGreg Smith, Chief Financial OfficerLiz Vaughan-Adams, Communications

+44 (0) 20 7444 0050+44 (0) 20 7444 0062/+44 (0) 7979 853802

Charlotte Street Partners

Andrew Wilson

+44 (0) 7810 636995

Martha Walsh

+44 (0) 7876 245962

 

Notes for editors

 

About IP Group

 

IP Group is a leading intellectual property commercialisation company which focuses on evolving great ideas, mainly from its partner universities, into world-changing businesses. The Group has pioneered a unique approach to developing these ideas and the resulting businesses by providing access to business building expertise, capital (through its 100%-owned FCA-authorised subsidiaries IP Capital and Parkwalk Advisors), networks, recruitment and business support. IP Group has a strong track record of success and its portfolio comprises holdings in early-stage to mature businesses across life sciences and technology. IP Group is listed on the Main Market of the London Stock Exchange under the code IPO.

Group holdings in portfolio companies reflect the undiluted beneficial equity interest excluding debt, unless otherwise explicitly stated.

For more information, please visit our website at www.ipgroupplc.com.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAVXLFBVEFXBBB
Date   Source Headline
2nd Sep 201911:48 amRNSHolding(s) in Company
19th Aug 20192:25 pmRNSHolding(s) in Company
13th Aug 20193:31 pmRNSHolding(s) in Company
1st Aug 20194:19 pmRNSHolding(s) in Company
15th Jul 20197:09 amRNSCeres Power signs collaboration with Doosan
15th Jul 20197:00 amRNSIstesso announces positive P2a study of MBS2320
9th Jul 20191:35 pmRNSHolding(s) in Company
9th Jul 201910:50 amRNSHolding(s) in Company
13th Jun 20197:00 amRNSAppointment of Non-executive Director
7th Jun 20195:12 pmRNSHolding(s) in Company
7th Jun 20191:19 pmRNSHolding(s) in Company
31st May 20197:00 amRNSHolding(s) in Company
28th May 20196:04 pmRNSHolding(s) in Company
28th May 20195:42 pmRNSResult of AGM
28th May 201911:13 amRNSAppointment of Caroline Brown as NED
16th May 20196:21 pmRNSWithdrawal of resolution from 2019 AGM
3rd May 20199:38 amRNSAppointment of corporate broker
26th Apr 20196:23 pmRNSLTIP & DBSP awards; DBSP option exercise
18th Apr 20192:54 pmRNSAnnual Financial Report
15th Apr 201911:55 amRNSHolding(s) in Company
11th Apr 20197:12 amRNSDiurnal positive advice from EMA for Chronocort
26th Mar 20197:00 amRNSFinal Results
19th Mar 20193:32 pmRNSHolding(s) in Company
8th Mar 20192:20 pmRNSHolding(s) in Company
5th Mar 20195:54 pmRNSHolding(s) in Company
12th Feb 20199:36 amRNSDirector Declaration
12th Feb 20199:03 amRNSFLF aims for fusion by mid 2019 on Machine 3
28th Jan 20197:00 amRNSPortfolio co Featurespace completes £25m round
18th Jan 20191:25 pmRNSHolding(s) in Company
3rd Jan 20198:56 amRNSHolding(s) in Company
11th Dec 20187:00 amRNSWaveOptics completes £20.0m funding round
10th Dec 20187:05 amRNSAvacta signs deal with LG Chem worth up to $310m
4th Dec 20185:49 pmRNSPortfolio co Ceres finalises deal with Weichai
3rd Dec 20187:00 amRNSUltrahaptics completes £35.0m funding round
31st Oct 20185:52 pmRNSDirector Declaration
18th Oct 20182:00 pmRNSAmgen invests £50m in Oxford Nanopore Technologies
15th Oct 20187:00 amRNSPortfolio co Garrison completes £22.9m financing
8th Oct 20187:07 amRNSPortfolio co Diurnal headline data for Chronocort
19th Sep 20189:51 amRNSDirector/PDMR Shareholding
17th Sep 20184:58 pmRNSDirector/PDMR Shareholding
17th Sep 20184:38 pmRNSDirector/PDMR Shareholding
17th Sep 201812:12 pmRNSDirector/PDMR Shareholding
17th Sep 20187:00 amRNSAppointment of Chairman; Board changes
31st Aug 20189:55 amRNSHolding(s) in Company
30th Aug 20187:00 amRNSGenomics announces Vertex leads £25m financing
29th Aug 20186:29 pmRNSIP Group plc -SAYE scheme
21st Aug 20187:06 amRNSCeres signs agreement with Bosch; £9m investment
10th Aug 20187:11 amRNSArtios Pharma completes £65m financing
31st Jul 20188:40 amRNSTR-1: NOTIFICATION
25th Jul 20187:00 amRNSHalf-yearly results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.